Leukocyte common antigen-negative, aggressive cutaneous anaplastic large cell lymphoma with prominent pseudocarcinomatous hyperplasia

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 74-77

  Sugiyama, Hiroko ^a   Asagoe, Kenji ^a   Morizane, Shin ^a   Oono, Takashi ^a   Okazaki, Fusako ^b   Iwatsuki, Keiji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Fukuyama City Hospital   (Japan)

Author keywords

Aggressive; Anaplastic large cell lymphoma; CD45; Leukocyte common antigen; Pseudocarcinomatous hyperplasia

Indexed keywords

ANTINEOPLASTIC AGENT; CD30 ANTIGEN; CD45 ANTIGEN; LYMPHOCYTE SURFACE MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA; DISEASE COURSE; EPIDERMIS HYPERPLASIA; FACE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; MALE; NULL CELL; PSEUDOCARCINOMATOUS HYPERPLASIA; SKIN LYMPHOMA; SKIN NODULE; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE RECEPTOR GENE; TUMOR CELL; TUMOR GROWTH; UNDIFFERENTIATED CARCINOMA;

ANTIGENS, CD45; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPLASIA; LYMPHATIC METASTASIS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MIDDLE AGED; NOSE NEOPLASMS; SKIN NEOPLASMS;

EID: 38549145971     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0343     Document Type: Article

References (13)

1. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
3. Krasne DL, Warnke RA, Weiss LM. Malignant lymphoma presenting as pseudoepitheliomatous hyperplasia. A report of two cases. Am J Surg Pathol 1988; 12: 835-42.
4. Courville P, Wechsler J, Thomine E, et al. Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression. The French Study Group on Cutaneous Lymphoma. Br J Dermatol 1999; 140: 421-6.
5. Cespedes YP, Rockley PF, Flores F, et al. Is there a special relationship between CD30-positive lymphoproliferative disorders and epidermal proliferation? J Cutan Pathol 2000; 27: 271-5.
6. Scarisbrick JJ, Calonje E, Orchard G, et al. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients. J Am Acad Dermatol 2001; 44: 239-47.
7. Yokote R, Iwatsuki K, Hashizume H, et al. Lymphomatoid papulosis associated with acquired ichthyosis. J Am Acad Dermatol 1994; 30: 889-92.
8. Kato N, Yasukawa K, Kimura K, et al. Anaplastic large-cell lymphoma associated with acquired ichthyosis. J Am Acad Dermatol 2000; 42: 914-20.
9. Lin JH, Lee JY. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia. J Cutan Pathol 2004; 31: 458-61.
10. Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 1995; 19: 407-16.
11. Burg G, Kempf W, Kazakov DV, et al. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol 2003; 148: 580-6.
12. Falini B, Pileri S, Stein H, et al. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. Hum Pathol 1990; 21: 624-9.
13. Perkins PL, Ross CW, Schnitzer B. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall. Arch Pathol Lab Med 1992; 116: 1192-6.